Bevacizumab 400mg Injection: Effective Treatment Solution

Bevacizab 400mg Injection

Description:

• Bevacizab 400mg Injection is an anticancer medicine containing the active ingredient Bevacizumab.
• It is used to prevent the growth of tumors and is indicated along with other chemotherapy drugs to treat various types of cancer.

Uses:

• Glioblastoma multiforme (brain cancer).
• Persistent, recurrent, or metastatic breast cancer.
• Metastatic cervical cancer.
• Advanced kidney cancer.
• Metastatic colorectal cancer.
• Advanced non-small-cell lung cancer.
• Liver cancer (Hepatocellular carcinoma).
• Cancers of the ovary, cervical, fallopian tube, or primary peritoneal cancer.

Therapeutic Effects:

• Bevacizab 400mg Injection is a recombinant humanized monoclonal antibody that works as a targeted therapy.
• It binds to the protein vascular endothelial growth factor A (VEGF-A), inhibiting the formation of blood vessels that supply oxygen and nutrients to the tumor.

Administration:

• Administered intravenously as an infusion.
• The infusion should be given immediately after dilution.

Safety Advice:

• Pregnancy: Inform your physician before starting treatment. The medicine may cause harm to the unborn baby.
• Breastfeeding: Avoid breastfeeding for at least 6 months after treatment.
• Lungs: Inform your doctor if you have any lung conditions.
• Liver: Inform your physician if you have liver diseases.
• Alcohol: Consult your doctor about alcohol consumption during treatment.
• Driving: Avoid driving or using machinery due to potential dizziness or sleepiness.

Interaction with Other Drugs:

• Inform your doctor about any prescribed medications, over-the-counter medicines, nutritional and vitamin supplements, and herbal products you take or have taken before the treatment.

Storage:

• Store Bevacizab 400mg Injection at 2˚C to 8˚C. Do not freeze or shake.
• Protect from light. Keep out of reach of children.

Side Effects:

• Serious: Headache, vision changes, confusion, severe allergic reactions, high blood pressure, delayed wound healing following surgery, protein in urine, severe infections, blood clots in arteries and blood vessels of lungs, gut perforation, nosebleeds and bleeding risk, heart problems with an increase in heart rate, mouth sores, dryness, shortness of breath.
• Common: Numbness in hands or feet, weakness and lack of energy, diarrhea, nausea, vomiting, abdominal pain, constipation, loss of appetite, weight loss, changes in taste and speech, decrease in counts of white blood cells, fever, dry skin, back pain.

FAQ:

1. Is Bevacizab 400mg Injection used as standalone treatment in cancers?

   • Bevacizab 400mg Injection can be used as monotherapy or in combination with chemotherapy or immunotherapy medications.

2. Is it safe for women to use Bevacizab 400mg Injection?

   • Women with reproductive potential should discuss effective birth control methods with their doctor during treatment and for at least 6 months after the last dose.

3. Is it safe to undergo surgery during the treatment with Bevacizab 400mg Injection?

   • Avoid surgery for 28 days before or after treatment due to the risk of bleeding and poor wound healing.

4. Do the side effects of Bevacizab 400mg Injection last for a chronic period?

   • Side effects occur until the drug concentration stays in the body, which is approximately 4 months after the final dose.

5. How is Bevacizab 400mg Injection administered?

   • Administered intravenously through infusion, with the amount of drug measured based on the patient’s body weight, height, and age. The first dose is administered for 90 minutes, and if well tolerated, the infusion time can be reduced to 30 minutes.

6. Can I take Bevacizab 400mg Injection if I am pregnant?

   • Inform your physician before starting treatment if you are pregnant or planning for pregnancy, as the medicine may cause harm to the unborn baby.

Fact Box:

• Molecule name: Bevacizumab
• Therapeutic class: Anticancer
• Pharmacological class: VEGF Inhibitor

Теги: cancer_treatment, chemotherapy, bevacizumab, medicine, injection